Clinical Trials Logo

Hypertrophy clinical trials

View clinical trials related to Hypertrophy.

Filter by:

NCT ID: NCT00589836 Completed - Clinical trials for Hypertrophic Cardiomyopathy

Assessment of Left Ventricular Torsion by Echocardiography Study

LVTorsion
Start date: June 2005
Phase: N/A
Study type: Observational

The purpose of this study is to learn about the twisting or wringing motion of the heartbeat called Left Ventricular Torsion (LV Torsion) which can be seen on ultrasound.

NCT ID: NCT00552032 Completed - Clinical trials for Adenoids Hypertrophy

Efficacy and Safety of Mometasone Furoate Nasal Spray in Children With Adenoid Hypertrophy. SNORE Study (P05155)

SNORE
Start date: August 1, 2007
Phase: Phase 3
Study type: Interventional

The purpose of this study is to determine whether 8 weeks treatment with mometasone furoate nasal spray (MFNS), twice daily, is safe and effective in treating adenoid hypertrophy in children.

NCT ID: NCT00542165 Completed - Clinical trials for BPH/LUTS/Sexual Functions

Multicenter Prospective Study on the Changes of Sexual Function Following Treatment With Alfuzosin (Xatral XL®) in Patients With Benign Prostate Hypertrophy

Start date: March 2004
Phase: Phase 4
Study type: Interventional

To collect under daily practice conditions, clinical data on the changes of sexual function when a new formulation of alfuzosin(Xatral XL® )is administered once daily in patients with lower urinary tract symptoms(LUTS) suggestive of prostatic hypertrophy

NCT ID: NCT00518479 Completed - Hypertension Clinical Trials

Pathophysiological Mechanisms of Hypertensive LVH:Optimising Regression

Start date: September 2003
Phase: N/A
Study type: Interventional

Uncontrolled high blood pressure can cause heart muscle 'thickening', and this increases the likelihood of complications and death. The high blood pressure explains some but not all of this increase in heart size. This study will investigate the other causes, and will measure the heart muscle 'thickness' very accurately using the latest and most accurate technique called cardiac magnetic resonance imaging (MRI). The best way to treat this heart thickening remains to be determined. We hope to be able to show that by specifically targeting the cause of heart muscle thickening we can reduce its occurrence more effectively than by other standard means of blood pressure treatment

NCT ID: NCT00503802 Completed - Clinical trials for Sleep Apnea Syndromes

Randomized Clinical Trial of Nasal Turbinate Reduction to Improve Continuous Positive Airway Pressure (CPAP) Outcomes for Sleep Apnea

TURBO
Start date: July 2007
Phase: Phase 2
Study type: Interventional

Obstructive sleep apnea occurs in 2-4% of middle age adults and results in significant morbidity and mortality. The first line therapy is provision of continuous positive airway pressure (CPAP) via a nasal mask chronically. Nasal resistance related to nasal turbinate enlargement may compromise CPAP treatment. This randomized double-blind sham-placebo-controlled trial tests the hypothesis that nasal turbinate reduction improves the nasal passage, CPAP use, and sleep apnea quality of life in newly diagnosed sleep apnea patients who are recommended CPAP therapy.

NCT ID: NCT00500552 Completed - Clinical trials for Hypertrophic Cardiomyopathy

Perhexiline Therapy in Patients With Hypertrophic Cardiomyopathy

METAL-HCM
Start date: December 2006
Phase: Phase 2
Study type: Interventional

Hypertrophic Cardiomyopathy (HCM) is a relatively common inherited heart muscle disease. Many patients experience symptoms of breathlessness, fatigue and chest pain. These symptoms are not always controlled with current therapies. Recently the investigators showed that a drug called Perhexiline markedly improved exercise capacity and symptoms in patients with heart failure. In this proposal the investigators wish to test whether Perhexiline improves exercise capacity and relieves symptoms in patients with HCM

NCT ID: NCT00497146 Completed - Clinical trials for Chronic Kidney Disease

The PRIMO Study: Paricalcitol Capsules Benefits Renal Failure Induced Cardiac Morbidity in Subjects With Chronic Kidney Disease Stage 3/4

PRIMO
Start date: February 2008
Phase: Phase 3
Study type: Interventional

To evaluate the effects of paricalcitol capsules on cardiac structure and function over 48 weeks in patients with Stage 3/4 chronic kidney disease (CKD) who had left ventricular hypertrophy (LVH).

NCT ID: NCT00475501 Completed - Sarcopenia Clinical Trials

5-Alpha Reductase and Anabolic Effects of Testosterone

Start date: January 2007
Phase: Phase 2
Study type: Interventional

The purpose of this study is to determine whether a higher-than-replacement dose of testosterone and finasteride can be combined to safely increase muscle strength in older men who have a low blood concentration of testosterone.

NCT ID: NCT00461123 Completed - Clinical trials for Prostatic Hypertrophy, Benign

Vardenafil in Greenlight(TM) Laser Surgery of Benign Prostate Hypertrophy

Start date: March 2007
Phase: Phase 2
Study type: Interventional

The greenlight laser has an absorption maximum which is exactly the same as for hemoglobin. In the presence of hemoglobin, its application causes vaporization of the tissue and this effect depends on the concentration of hemoglobin in the respective tissue. Therefore, increase of blood-flow in the tissue (here: prostate gland) should exert better efficacy of the laser application and consequently shortening of the required duration of laser application.

NCT ID: NCT00446563 Completed - Clinical trials for Hypertension; Hypertrophy, Left Ventricular

Efficacy and Safety of Valsartan in Combination With Amlodipine Compared to Losartan Plus Hydrochlorothiazide in Patients With Hypertension and Left Ventricular Hypertrophy

Start date: March 2007
Phase: Phase 3
Study type: Interventional

This study will evaluate the safety and efficacy of amlodipine plus valsartan in patients with hypertension and left ventricular hypertrophy